MGMT and Sepsis: Although more experiments are required for an in-depth understanding of the mechanisms involved, our initial results support a possible extended use of an MGMT inhibitor (Lomeguatrib), a chemotherapeutic agent [95], on the attenuation of sepsis hyper-inflammation.